<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03879525</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00056740</org_study_id>
    <nct_id>NCT03879525</nct_id>
  </id_info>
  <brief_title>EMR Outcomes: Anxiety and Depression in Epilepsy</brief_title>
  <official_title>Anxiety and Depression in Epilepsy: Assessing Outcomes Using the Electronic Medical Record (EMR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to find out how people with epilepsy and possible symptoms of
      anxiety or depression are doing for 6 months after a regular epilepsy clinic visit.
      Participants in this study will complete questionnaires either by phone or via the patient
      portal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study among N=30 individuals with epilepsy and high or borderline anxiety or
      depression symptoms receiving usual care at the Wake Forest Comprehensive Epilepsy Center.
      Participants are randomized to one of two outcome assessment methods
      [EMR-based-interventional method vs. telephone-based-standard method] for collecting quality
      of life, anxiety and depression outcomes at 3 and 6 months, under usual care management.

      The primary aim of the study is to assess feasibility of EMR-based outcome assessment by
      measuring 6-month retention.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcome group assignment will not be blinded to the primary investigator or primary study coordinator, as it will be necessary for these individuals to know outcome assessment allocation in order for outcome collection to occur. When possible, outcome group assignment will not be shared with the epilepsy provider managing the participant, in an effort to reduce any potential bias in retention that could be introduced by the provider in clinical interactions with the participant.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of participants retained in the study in the EMR arm</measure>
    <time_frame>6 months</time_frame>
    <description>Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments in the EMR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants retained in the study in the Phone arm</measure>
    <time_frame>6 months</time_frame>
    <description>Retention is defined as the percentage of participants in the study who complete the 6 month outcome instruments via phone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>Baseline</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>3 Months</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life in Epilepsy-10 (QOLIE-10)</measure>
    <time_frame>6 Months</time_frame>
    <description>QOLIE-10 is A brief questionnaire (10-items) to screen for quality of life in epilepsy. Total Score 10-50. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>6 months</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>Baseline</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>3 Months</time_frame>
    <description>Anxiety scale. Total Score 0-28. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>Baseline</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>3 Months</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Disorders Depression Inventory (NDDI-E)</measure>
    <time_frame>6 Months</time_frame>
    <description>The NDDI-E is a 6-item questionnaire validated to screen for depression in people with epilepsy. Total Score 4-24. Higher scores denotes worse outcomes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Quality of Life</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>EMR Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants assigned to this arm will complete the questionnaires in the EMR using the EMR-based-interventional method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phone Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants assigned to this arm will complete the questionnaires via the Phone using the Telephone-based-standard method.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EMR-based-interventional method</intervention_name>
    <description>Questionnaire delivery method. Participants will complete standard care anxiety and depression screening and quality of life assessment directly into the patient entered section of the EMR, administered on arrival in the clinic.</description>
    <arm_group_label>EMR Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telephone-based-standard method</intervention_name>
    <description>Questionnaires delivered via phone. Participants will complete standard care anxiety and depression screening and quality of life assessment via phone. Standart delivery method.</description>
    <arm_group_label>Phone Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Completed electronic questionnaires independently in clinic

          -  Epilepsy diagnosis (clinician impression or EEG-based)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heidi M. Munger Clary, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia. 2017 Jun;58(6):973-982. doi: 10.1111/epi.13769. Epub 2017 May 3.</citation>
    <PMID>28470748</PMID>
  </reference>
  <reference>
    <citation>Kwan P, Yu E, Leung H, Leon T, Mychaskiw MA. Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy. Epilepsia. 2009 May;50(5):1059-66. doi: 10.1111/j.1528-1167.2008.01938.x. Epub 2008 Dec 15.</citation>
    <PMID>19170734</PMID>
  </reference>
  <reference>
    <citation>Fazel S, Wolf A, Långström N, Newton CR, Lichtenstein P. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet. 2013 Nov 16;382(9905):1646-54. doi: 10.1016/S0140-6736(13)60899-5. Epub 2013 Jul 22.</citation>
    <PMID>23883699</PMID>
  </reference>
  <reference>
    <citation>Au A, Leung P, Kwok A, Li P, Lui C, Chan J. Subjective memory and mood of Hong Kong Chinese adults with epilepsy. Epilepsy Behav. 2006 Aug;9(1):68-72. Epub 2006 May 11.</citation>
    <PMID>16697262</PMID>
  </reference>
  <reference>
    <citation>Caller TA, Chen JJ, Harrington JJ, Bujarski KA, Jobst BC. Predictors for readmissions after video-EEG monitoring. Neurology. 2014 Jul 29;83(5):450-5. doi: 10.1212/WNL.0000000000000647. Epub 2014 Jun 20.</citation>
    <PMID>24951478</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>March 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2019</study_first_posted>
  <last_update_submitted>April 16, 2020</last_update_submitted>
  <last_update_submitted_qc>April 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electronic medical record</keyword>
  <keyword>EMR</keyword>
  <keyword>Patient Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will consider requests if received.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

